PACLX
Price
$35.20
Change
+$0.15 (+0.43%)
Updated
Jan 30 closing price
Net Assets
66.07B
VLAAX
Price
$41.69
Change
+$0.21 (+0.51%)
Updated
Jan 30 closing price
Net Assets
903.02M
Ad is loading...

PACLX vs VLAAX

Header iconPACLX vs VLAAX Comparison
Open Charts PACLX vs VLAAXBanner chart's image
T. Rowe Price Capital Appreciation Adv
Price$35.20
Change+$0.15 (+0.43%)
VolumeN/A
Net Assets66.07B
Value Line Asset Allocation Investor
Price$41.69
Change+$0.21 (+0.51%)
VolumeN/A
Net Assets903.02M
PACLX vs VLAAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PACLX vs. VLAAX commentary
Jan 31, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PACLX is a StrongBuy and VLAAX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
PACLX has more cash in the bank: 66.1B vs. VLAAX (903M). PACLX pays higher dividends than VLAAX: PACLX (1.77) vs VLAAX (0.95). PACLX was incepted earlier than VLAAX: PACLX (20 years) vs VLAAX (31 years). PACLX is a more actively managed with annual turnover of: 65.10 vs. VLAAX (29.00). VLAAX has a lower initial minimum investment than PACLX: VLAAX (1000) vs PACLX (2500). PACLX annual gain was more profitable for investors over the last year : 6.99 vs. VLAAX (2.07). PACLX return over 5 years is better than : 18.85 vs. VLAAX (8.76).
PACLXVLAAXPACLX / VLAAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence20 years31 years-
Gain YTD3.4082.837120%
Front LoadN/AN/A-
Min. Initial Investment25001000250%
Min. Initial Investment IRAN/AN/A-
Net Assets66.1B903M7,320%
Annual Yield % from dividends1.770.95187%
Returns for 1 year6.992.07339%
Returns for 3 years5.55-0.08-7,096%
Returns for 5 years18.858.76215%
Returns for 10 years53.1855.8295%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OR18.610.15
+0.81%
Osisko Gold Royalties Ltd
PMCB1.620.01
+0.47%
PharmaCyte Biotech
WLKP24.44-0.08
-0.33%
Westlake Chemical Partners LP
GEVO1.77-0.01
-0.56%
Gevo
MANH214.14-8.70
-3.90%
Manhattan Associates